Better Therapeutics, Inc. (BTTX) News & Overview - Discounting Cash Flows
BTTX
Better Therapeutics, Inc.
BTTX (OTC)

BTTX's Business Model

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Sector & Industry Healthcare / Biotechnology
Website https://www.bettertx.com
CEO (Chief Executive Officer) David P. Perry
Number of Employees
IPO date March 17, 2021

BTTX Latest News

Contact
CountryUS
Address548 Market Street
CitySan Francisco
StateCA
Phone415 887 2311
Zip Code94104
Other Identifiers
CIK0001832415
ISINUS08773T1043
CUSIP08773T104
Open0.0001
Previous Close0.0001
Volume172
Average Volume11.8 Thou.
Day’s Range0.0001 – 0.0001
52 Week Range0.0001-0.016
MA (50)0.000128
MA (200)0.0001615
Market Cap5.45 Thou.
Shares Out.54.52 Mil.
Earnings DateJul 21, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for BTTX

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us